Tag: Finerenone

AHA Names 7 Cardiovascular Research Breakthroughs in 2024

Expert
Prof. Rachel Giles
Conference
AHA 2024

19 December 2024 11:40

FINEARTS-HF: Finerenone improves outcomes in heart failure with preserved ejection fraction

Presented By
Prof. Scott Solomon, Brigham and Women's Hospital, MA, USA
Trial
Phase 3, FINEARTS-HF
Conference
ESC 2024
Type
Peer-reviewed article

7 November 2024 11:45

Heart failure: the 2023 update

Presented By
Prof. Theresa McDonagh; Prof. Roy Stuart Gardner; Prof. Alexandre Mebazaa; Prof. Ewa Jankowska; Prof. Marianna Adamo
Conference
ESC 2023
Type
Peer-reviewed article

30 October 2023 16:05

FIDELITY: Cardiorenal benefits of finerenone, regardless of LVH status

Presented By
Prof. Gerasimos Filippatos , Attikon University Hospital, Greece
Trial
Phase 3, FIDELIO-DKD, FIGARO-DKD
Conference
HFA 2022
Type
Peer-reviewed article

28 July 2022 12:09

Antagonising the mineralocorticoid receptor beneficial for patients with diabetes and CKD

Presented By
Prof. Bertram Pitt, University of Michigan School of Medicine, USA
Trial
Phase 3, FIGARO-DKD
Conference
ESC 2021
Type
Peer-reviewed article

26 October 2021 12:40

Finerenone reduces the risk of AF onset in patients with CKD and diabetes

Presented By
Prof. Gerasimos Filippatos, Attikon University Hospital, Greece
Trial
Phase 3, FIDELIO-DKD
Conference
ACC 2021
Type
Peer-reviewed article

9 July 2021 13:46

Finerenone lowers CV events in diabetic CKD patients

Presented By
Prof. Gerasimos Filippatos, National and Kapodistrian University of Athens, Greece
Trial
Phase 3, FIDELIO-DKD
Conference
AHA 2020
Type
Peer-reviewed article

18 February 2021 11:33
site created by:   

© 2024 Medicom Medical Publishers.  All rights reserved. Terms and Conditions | Privacy Policy



HEAD OFFICE
Laarderhoogtweg 25
1101 EB Amsterdam
The Netherlands
T: +31 85 4012 560
E: publishers@medicom-publishers.com